TI
IOVA icon

Trexquant Investment’s Iovance Biotherapeutics IOVA Stock Holding History

Trexquant Investment’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-140,325
Closed -$2.08M – 1679
2024
Q1 		$2.08M Buy
+140,325
New +$1.63M 0.04% 635
2023
Q2 		– Sell
-280,846
Closed -$1.72M – 1599
2023
Q1 		$1.72M Buy
280,846
+104,220
+59% +$719K 0.05% 514
2022
Q4 		$1.13M Buy
+176,626
New +$1.38M 0.03% 606
2022
Q1 		– Sell
-13,657
Closed -$261K – 1532
2021
Q4 		$261K Sell
13,657
-9,995
-42% -$220K 0.02% 1001
2021
Q3 		$583K Buy
+23,652
New +$557K 0.05% 477
2021
Q2 		– Sell
-34,757
Closed -$1.1M – 1286
2021
Q1 		$1.1M Buy
+34,757
New +$1.44M 0.1% 253
2020
Q4 		– Sell
-16,733
Closed -$551K – 1245
2020
Q3 		$551K Sell
16,733
-31,137
-65% -$955K 0.04% 638
2020
Q2 		$1.31M Buy
+47,870
New +$1.57M 0.09% 312
2019
Q2 		– Sell
-55,079
Closed -$524K – 964
2019
Q1 		$524K Buy
+55,079
New +$535K 0.04% 576
2018
Q4 		– Sell
-24,732
Closed -$278K – 1157
2018
Q3 		$278K Buy
24,732
+14,618
+145% +$207K 0.02% 708
2018
Q2 		$129K Buy
+10,114
New +$148K 0.01% 825
2018
Q1 		– Sell
-15,464
Closed -$124K – 1220
2017
Q4 		$124K Sell
15,464
-24,126
-61% -$194K 0.01% 994
2017
Q3 		$307K Buy
+39,590
New +$251K 0.08% 458
2017
Q2 		– Sell
-26,449
Closed -$197K – 956
2017
Q1 		$197K Buy
+26,449
New +$194K 0.03% 964
2016
Q4 		– Sell
-14,652
Closed -$121K – 1040
2016
Q3 		$121K Buy
+14,652
New +$124K 0.03% 681
2016
Q2 		– Sell
-27,660
Closed -$141K – 970
2016
Q1 		$141K Buy
+27,660
New +$151K 0.02% 861

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Trexquant Investment's IOVA Position: Q2 2024 in Review

Trexquant Investment sold out of Iovance Biotherapeutics (IOVA) in Q2 2024, closing a stake of 140,325 shares — an estimated $2.08M sold.

Trexquant Investment first reported a position in IOVA in Q1 2016 and held it in 16 quarters. The position peaked at $2.08M in Q1 2024. 295 funds tracked by Wall St. Rank hold IOVA as of Q2 2024.

  • Trexquant Investment reported no remaining Iovance Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Trexquant Investment sold 140,325 Iovance Biotherapeutics shares in Q2 2024, an estimated $2.08M.
  • Trexquant Investment first reported a position in Iovance Biotherapeutics in Q1 2016 and held it in 16 quarters.
  • Trexquant Investment's Iovance Biotherapeutics position peaked at $2.08M in Q1 2024.
  • 295 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2024.

Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.